Paid Clinical Trials in The Woodlands, TX
As of July 2026, 113 paid clinical trials are recruiting in The Woodlands, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
The Woodlands offers studies at sites including Houston Methodist The Woodlands Hospital for conditions such as Non-Small Cell Lung Cancer, Age-Related Macular Degeneration, Carcinoma, Non-Small-Cell Lung, Geographic Atrophy. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in The Woodlands
Trials by drug in The Woodlands
Filter results
103 clinical trials
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Top Research Study Locations in The Woodlands
Researchers run research studies in The Woodlands, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Houston Methodist The Woodlands Hospital | Anatomic Stage II Breast Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, AL Amyloidosis | 17 |
| Renovatio Clinical | Lymphoma, Non-Small Cell Lung Cancer, Alpha 1-Antitrypsin Deficiency | 12 |
| Retina Consultants of Texas | Geographic Atrophy, AMD, Age - Related Macular Degeneration (AMD) | 10 |
| Texas Oncology - Gulf Coast | Non-Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma | 10 |
| Family Psychiatry Of The Woodlands | Generalized Anxiety Disorder (GAD), Bipolar I Disorder, Bipolar II Disorder | 7 |
| Advanced Rheumatology of Houston | Sjögren's Syndrome, Systemic Lupus Erythematosus (SLE), Radiographic Axial Spondyloarthritis | 3 |
| Texas Oncology - The Woodlands | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Neoadjuvant | 3 |
| Advanced Rheumatology of Houston - Woodlands | Osteoarthritis, Overweight or Obesity, Psoriatic Arthritis | 2 |
| Retina Consultants Texas | Geographic Atrophy (GA), Age-related Macular Degeneration (AMD) | 2 |
| Retina Consultants of Texas (Woodlands) | Macular Edema Secondary to Inflammation | 2 |
| Texas Oncology Gulf Coast | Immune Thrombocytopenia (ITP), Myelodysplastic Syndromes | 2 |
| The Woodlands, TX | Branch Retinal Vein Occlusion (BRVO), Neovascular (Wet) Age-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration (NVAMD) | 2 |
| US Oncology Research Network | Neoplasm Metastasis, Breast Neoplasms, Carcinoma, Transitional Cell | 2 |
| Texas Oncology-The Woodlands | Brain Tumor, Brain Tumor - Metastatic, Brain Tumor, Adult Meningioma | 2 |
| US Oncology | Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms | 1 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Ability and Beyond | 22q11.2 Deletion Syndrome, Autism Spectrum Disorder, Autism Spectrum Disorder (ASD | 1 |
| Advanced Rheumatology of Houston - The Woodlands | Psoriatic Arthritis | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Align Clinic | Scoliosis Idiopathic Adolescent Treatment | 1 |
| Elligo Health Research/The Woodlands Dermatology Associates | Hidradenitis Suppurativa | 1 |
| Family Psych of The Woodlands | Attention-Deficit/Hyperactivity Disorder | 1 |
| Houston Methodist The Woodlands | Rotator Cuff Tears | 1 |
| MD Anderson Regional Care Center-The Woodlands | Acute Promyelocytic Leukemia With PML-RARA | 1 |
| MD Anderson in The Woodlands | Inflammatory Breast Carcinoma, Invasive Breast Carcinoma, Second Primary Malignant Neoplasm | 1 |
Active & Upcoming Studies in The Woodlands (2026)
Recruiting trials in The Woodlands grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (49 active studies)
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · Phase 2 · Regeneron Pharmaceuticals
- Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · Phase 1, Phase 2 · Pfizer
Eye & vision (19 active studies)
- Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration · Phase 1, Phase 2 · Eyconis INC.
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
Mental health & behavior (4 active studies)
- A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder · Phase 2 · AbbVie
- Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder · Phase 2 · AbbVie
Diabetes & metabolic (2 active studies)
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) · Phase 4 · Eli Lilly and Company
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease · Phase 3 · Prokidney
Neurology & pain (2 active studies)
- Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine · Phase 3 · AbbVie
- Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17) · Phase 3 · AbbVie
Pediatric (1 active study)
- Rethinking Rigidity: Development of a 3D-Printed Scoliosis Brace With Varying Flexibility · Baylor College of Medicine
Common conditions studied in The Woodlands
- Non-Small Cell Lung Cancer (4 active studies)
- Age-Related Macular Degeneration (3 active studies)
- Carcinoma, Non-Small-Cell Lung (3 active studies)
- Geographic Atrophy (3 active studies)
- Geographic Atrophy (GA) (3 active studies)
- Neoplasm Metastasis (3 active studies)
Leading research sponsors in The Woodlands
- AbbVie
- Pfizer
- Eli Lilly and Company
- Hoffmann-La Roche
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in The Woodlands?
There are approximately 113 recruiting clinical trials in The Woodlands, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in The Woodlands pay participants?
Most recruiting trials in The Woodlands compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in The Woodlands?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in The Woodlands?
The most common conditions under active study in The Woodlands include Non-Small Cell Lung Cancer (4), Age-Related Macular Degeneration (3), Carcinoma, Non-Small-Cell Lung (3), Geographic Atrophy (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in The Woodlands?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in The Woodlands on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in The Woodlands?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in The Woodlands?
Recruiting research sites in The Woodlands include Houston Methodist The Woodlands Hospital, Renovatio Clinical, Retina Consultants of Texas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in The Woodlands right now?
The largest active categories in The Woodlands are Cancer & tumors (49), Eye & vision (19), Mental health & behavior (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.